Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
OZEMPIC is indicated: •as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. •to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease. • to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease.
- generic_name
- semaglutide
- product_names
- semaglutide
- ndc
- 0169-4136, 0169-4132, 0169-4130, 0169-4772, 0169-4181, 0169-4136-11, 0169-4136-02, 0169-4132-90, 0169-4132-97, 0169-4132-11, 0169-4132-12, 0169-4130-01, 0169-4130-13, 0169-4772-11, 0169-4772-12, 0169-4772-90, 0169-4772-97, 0169-4181-03, 0169-4181-13, 0169-4181-90, 0169-4181-97
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en